Author

L. Hopcroft

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

C. Munje· 1 shared D. Vetrie· 1 shared E. Gomez-Castaneda· 1 shared H. Jorgensen· 1 shared J. Bittencourt-Silvestre· 1 shared M. Copland· 1 shared S. Rogers· 1 shared T. Holyoake· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Munje

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tyrosine kinase inhibitor independent gene expression signature in CML offers new targets for LSPC eradication therapy

E. Gomez-Castaneda, S. Rogers, C. Munje, J. Bittencourt-Silvestre, M. Copland, D. Vetrie, L. Hopcroft, H. Jorgensen, T. Holyoake

The paper identifies TKI-independent genes in CML LSC that could be targeted for new therapies, showing that gemtuzumab-ozogamicin and cyclosporine A have stronger effects on CML cells than healthy cells.

Cancers · Oct 26, 2022Peer-reviewedCancer Biology